The size of the European Cannabidiol Market is projected to witness a CAGR of 21.26% between 2022 to 2027 and be worth USD 8.96 billion by 2027 from USD 3.42 billion in 2022.
The legalization of the cultivation of cannabis in most of the countries in Europe is undoubtedly a key factor for the market to grow. CBD oils have many health benefits, especially in treating cancer tumor cells. Cannabidiol also has various advantages in the industries such as textiles, pharmaceuticals, and others, which also elevate the market's demand to the extent. Increasing incidences of chronic diseases associated with adopting a sedentary lifestyle also fuel the growth rate of the European cannabidiol Market. Moreover, the use of cannabidiol reduces inflammation anxiety and acts as a sleeping aid, which also proved to lower the frequency of seizures. All these benefits are adding value to the CBD oil in the market. Along with this, the government's rising investments in the development of new products using CBD oil are leveraging this market's growth rate. Also, growing support from private organizations through funds significantly influences the demand of the European CBD Oil market.
However, fluctuations in the availability of raw materials in the pharmaceutical companies and the growing cost of the products are hindering factors for the market in Europe. In addition, the lack of proper knowledge over the use of CBD oil in various fields is quietly hampering the market's growth rate. Finally, increasing risk factors with the long-term use of medicinal products is degrading the growth rate of the European CBD Oil market.
This research report on the European cannabidiol market has been segmented & sub-segmented into the following categories:
By Type:
By Distribution Channel:
By End Users:
By Country:
Geographically, the Europe cannabidiol market accounted for the second-largest share in the global market in 2020 and also is expected to account for a substantial share in the worldwide market during the forecast period owing to increasing expenditure on healthcare with the rising disposable income in developed countries and Increasing approvals from the government organizations for the new product launches.
The German Cannabidiol Market is the most lucrative regional market in Europe. Rising awareness of the benefits of CBD oil in healthcare and growing prevalence to improve the quality of the treatment procedures are majorly fuelling the demand for cannabidiol in Germany. Also, increasing funds from both public and private organizations are escalating the market's growth rate. Besides, the rapid adoption of these products in pharmaceutical companies creates growth opportunities for the market. Furthermore, the launch of innovative products in favor of the end-users and the introduction of reimbursement policies promote the market's growth rate.
The UK cannabidiol market is expected to grow at the highest CAGR during the forecast period. Increasing incidences of chronic diseases and the rising efficacy of CBD oil, which is derived from cannabis, are accelerating the market's demand.
KEY MARKET PLAYERS:
Companies dominating the European Cannabidiol Market profiled in this report are Pharmahemp d.o.o, ENDOCA, NuLeaf Naturals LLC, Folium Biosciences, Elixinol, Cannoid LLC, Medical Marijuana Inc., and Isodiol International Inc.
1. Introduction
1.1 Market Definition
1.2 Scope of the report
1.3 Study Assumptions
1.4 Base Currency, Base Year and Forecast Periods
2. Research Methodology
2.1 Analysis Design
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Data Modelling
2.2.4 Expert Validation
2.3 Study Timeline
3. Report Overview
3.1 Executive Summary
3.2 Key Inferencees
4. Market Dynamics
4.1 Impact Analysis
4.1.1 Drivers
4.1.2 Restaints
4.1.3 Opportunities
4.2 Regulatory Environment
4.3 Technology Timeline & Recent Trends
5. Competitor Benchmarking Analysis
5.1 Key Player Benchmarking
5.1.1 Market share analysis
5.1.2 Products/Service
5.1.3 Regional Presence
5.2 Mergers & Acquistion Landscape
5.3 Joint Ventures & Collaborations
6. Market Segmentation
6.1 CBD Oil Market, By Source Type
6.1.1 Marijuana
6.1.2 Hemp
6.1.3 Market Size Estimations & Forecasts (2019-2024)
6.1.4 Y-o-Y Growth Rate Analysis
6.1.5 Market Attractiveness Index
6.2 CBD Oil Market, By Distribution Channel
6.2.1 B2C
6.2.2 B2B
6.2.3 Market Size Estimations & Forecasts (2019-2024)
6.2.4 Y-o-Y Growth Rate Analysis
6.2.5 Market Attractiveness Index
6.3 CBD Oil Market, By End-Use
6.3.1 Personal Care & Cosmetics
6.3.2 Food & Beverages
6.3.3 Pharmaceuticals
6.3.4 Market Size Estimations & Forecasts (2019-2024)
6.3.5 Y-o-Y Growth Rate Analysis
6.3.6 Market Attractiveness Index
7. Geographical Landscape
7.1 Global Identity Governance and Administration Market, by Region
7.2 Europe
7.2.1 By Country
7.2.1.1 UK
7.2.1.2 France
7.2.1.3 Germany
7.2.1.4 Spain
7.2.1.5 Italy
7.2.1.6 Rest of Europe
7.2.2 By Source Type
7.2.3 By Distribution Channel
7.2.4 By End-Use
8. Key Player Analysis
8.1 Pharmahemp d.o.o
8.1.1 Business Description
8.1.2 Products/Service
8.1.3 Financials
8.1.4 SWOT Analysis
8.1.5 Recent Developments
8.1.6 Analyst Overview
8.2 ENDOCA
8.3 NuLeaf Naturals LLC
8.4 Folium Biosciences
8.5 Elixinol
8.6 Cannoid LLC
8.7 Medical Marijuana Inc
8.8 Isodiol International Inc
9. Market Outlook & Investment Opportunities
10. Appendix
List of Tables
List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
